Skip to main content
Uni-Bio Science Group Limited logo

Uni-Bio Science Group Limited — Investor Relations & Filings

Ticker · 690 HKEX Manufacturing
Open in API
Filings indexed 1,066 across all filing types
Latest filing 2009-09-02 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 690

About Uni-Bio Science Group Limited

http://www.uni-bioscience.com

Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise specializing in the R&D, manufacturing, and sales of biological and chemical pharmaceutical products. The company's core strategy centers on regenerative medicine, focusing on therapeutic areas such as endocrinology, dermatology, and ophthalmology. Key research pipelines address bone and muscle regeneration (including osteoporosis), skin and tissue repair (burns, chronic wounds, and medical aesthetics), and ocular regeneration (corneal damage and macular degeneration). Unique technological platforms include the ECO-KSFA® micro-protein manufacturing system for high-stability biologics and smart hydrogel technology for advanced tissue engineering and targeted delivery solutions.

Recent filings

Filing Released Lang Actions
CAPITAL REORGANISATION AND CHANGE IN BOARD LOT SIZE - ODD LOTS MATCHING SERVICE
Capital/Financing Update Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding a capital reorganisation and change in board lot size, specifically about the appointment of a broker to provide odd lots matching services. It references previous announcements and a circular related to the capital reorganisation. The document is relatively short (3639 characters) and does not contain financial statements or detailed financial data. It is an update on capital structure changes and related services rather than a full financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2009-09-02 English
Next Day Disclosure Return
Share Issue/Capital Change Classification · 100% confidence The document is a disclosure return filed by a listed issuer, Uni-Bio Science Group Limited, regarding changes in issued share capital and share buybacks. It references specific rules from the Hong Kong Stock Exchange Listing Rules (rule 13.25A and rule 10.06(4)(a)) that govern disclosures of share capital changes and share repurchases. The document includes detailed tables showing share consolidation and repurchase information, with no financial statements or management discussion. It is a regulatory disclosure about capital changes rather than a financial report or earnings release. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is sufficient and contains substantive data about share capital changes, not just an announcement or certification, so it is not RPA or RNS.
2009-08-31 English
EFFECTIVE DATE OF THE CAPITAL REORGANISATION AND ADJUSTMENTS TO THE EXERCISE PRICE OF, AND THE NUMBER OF SHARES ISSUABLE UPON EXERCISE OF THE OUTSTANDING OPTIONS
Capital/Financing Update Classification · 95% confidence The document is an announcement from Uni-Bio Science Group Limited regarding the effective date of a Capital Reorganisation and adjustments to the exercise price and number of shares issuable upon exercise of outstanding options. It includes detailed information about the court sanction, registration dates, timetable for the capital reorganisation, and specific adjustments to share options. The content focuses on changes to the company's capital structure and share option scheme, which aligns with updates on company fundraising, financing activities, or capital structure changes. The document is not a full financial report, earnings release, or management discussion, nor is it a regulatory filing or announcement of a report publication. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (8921 characters) and detailed content support this classification with high confidence.
2009-08-25 English
PROXY FORM
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a form of proxy for shareholders to vote at the Annual General Meeting (AGM) of Uni-Bio Science Group Limited. It includes instructions for appointing a proxy and voting on resolutions such as approval of audited financial statements, re-election of directors, appointment of auditors, and share mandates. This type of document is typically distributed to shareholders before or in conjunction with an AGM to facilitate voting. It is not the AGM presentation materials themselves, nor is it the announcement of voting results. It is a proxy solicitation document, which falls under the category of Proxy Solicitation & Information Statement (PSI). The document length is about 5294 characters, which is consistent with a detailed proxy form. Therefore, the correct classification is PSI with high confidence.
2009-08-25 English
GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF DIRECTORS, PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a circular from the Board of Uni-Bio Science Group Limited dated 26 August 2009. It contains detailed information about the upcoming Annual General Meeting (AGM) scheduled for 25 September 2009, including the notice of the meeting, proposed resolutions such as general mandates to issue and repurchase shares, re-election of directors, and amendments to the Articles of Association. It also includes proxy form instructions and appendices with explanatory statements and director details. The document is comprehensive and clearly intended to inform shareholders about the AGM and the matters to be voted on. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the AGM. It is not a full annual report or financial report, nor is it a voting results announcement or proxy solicitation alone. Therefore, the correct classification is AGM Information (AGM-R). The document length (15,000 characters) and content confirm it is the circular itself, not just an announcement of a report.
2009-08-25 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a detailed notice of an Annual General Meeting (AGM) for Uni-Bio Science Group Limited. It includes the date, time, and location of the meeting, agenda items such as approval of audited financial statements, re-election of directors, re-appointment of auditors, and special resolutions regarding share allotment and amendments to articles of association. The content is typical of an AGM notice, which is a formal announcement to shareholders about the meeting and the business to be transacted. There is no indication that this is the actual annual report or financial statements, but rather a notice to convene the meeting where such reports will be considered. The document length (15,000 characters) is consistent with a comprehensive AGM notice. Therefore, the appropriate classification is AGM Information (AGM-R).
2009-08-25 English

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.